Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-04-06

Clinical Trial Update: Role of Pioglitazone in Preventing Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pioglitazone for diabetes prevention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: M.V. Hospital for Diabetes | Conditions: Diabetes | Phase 1 | Status: COMPLETED